Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?
Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the development of novel therapies for inflammatory and immune-related illnesses with significant unmet medical needs. What is happening? According to EDSA, an independent Data and Safety Monitoring Board (DSMB) performed an interim […]
CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?
CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading session. CureVac is a multinational biopharmaceutical corporation specializing in messenger RNA (mRNA) technology. CVAC has more than 20 years of experience designing and refining versatile biological molecule for medical applications. Significant […]
Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update
Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market trading session. With 142 granted patents as of March 31, 2021, AnPac Bio is a biotechnology firm that works on early cancer screening and diagnosis as well as cancer therapy. Significant […]
VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?
VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower is a sustainable energy services company that specializes in battery storage, electric solutions for tailored and ruggedized fleet applications, solar, and essential power technologies and services. What is happening? Acces Industrial […]
Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?
Orphazyme Inc. (NASDAQ: ORPH) stock declined by 10.18% at last close whereas the ORPH stock price fell during the pre-market trading session by 58.18%. Orphazyme is a late-stage pharmaceutical business that is pioneering the use of heat shock proteins to treat uncommon illnesses. What is happening? Following its evaluation of the new drug application for […]
Arrival Inc. (ARVL) stock falls during pre-market trading. Here’s what you should know?
Arrival Inc. (NASDAQ: ARVL) stock plunged by 4.96% at last close while the ARVL stock price declines by 9.68% in the pre-market trading session. With its totally new approach to the design and manufacturing of electric vehicles, Arrival is redefining the automobile industry. Low-capital-cost, fast scalable Microfactories, paired with unique in-house designed components, materials, and […]
Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?
Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14 per share. Later in the after-market session, ICON stock gained 6.05% and reached $3.33 per share. ICON shares have risen 170.69% over the last 12 months, and they have moved up […]
Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?
Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour session. Cleveland BioLabs, Inc. is a biopharmaceutical firm that is working on new ways to stimulate the immune system and treat critical medical conditions. Current update Cleveland BioLabs stated that the […]
Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?
Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE’s stock lost -2.97% to close Thursday’s normal trading session at $16.31 per share. ACRE shares have risen 79.88% over the last 12 months, and they have moved down 1.69% in the […]
Why Zomedica Corp. (ZOM) stock jumped on Thursday?
Zomedica Corp. (ZOM) shares were climbed 4.04% in after-hours on Thursday, June 17, 2021, and close the day at $0.94 per share. Earlier, ZOM’s stock gained 0.74% to close Thursday’s normal trading session at $0.90 per share. ZOM shares have risen 310.68% over the last 12 months, and they have moved down 3.81% in the […]
